Literature DB >> 4425918

Carbohydrate tolerance and insulin responses in obstructive jaundice.

N G Soler, P D Exon, A Paton.   

Abstract

Twenty-three patients with obstructive jaundice were given a 50-g oral glucose tolerance test (G.T.T.) and an insulin stimulation test with oral glucose and intravenous tolbutamide and glucagon. An abnormal glucose response was as common in patients with carcinoma of the pancreas (seven out of 12) as in patients with "other" causes of obstructive jaundice (six out of 11). Though both groups had a low and delayed insulin response the insulin levels were significantly lower in patients with carcinoma of the pancreas. After the insulin stimulation test patients with obstructive jaundice who did not have carcinoma of the pancreas had a greater and significantly different insulin response from patients with pancreatic cancer. There was, however, considerable overlapping between the results of individual patients in the two groups.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4425918      PMCID: PMC1612510          DOI: 10.1136/bmj.4.5942.447

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Abnormal carbohydrate metabolism in pancreatic carcinoma.

Authors:  R MURPHY; F H SMITH
Journal:  Med Clin North Am       Date:  1963-03       Impact factor: 5.456

3.  The association of diabetes mellitus with primary carcinoma of the pancreas.

Authors:  F G SCHLESINGER; F SCHWARZ; C A WAGENVOORT
Journal:  Acta Med Scand       Date:  1960-04-20

4.  Carcinoma of the pancreas. I. A clinical and pathologic study of 609 necropsied cases. II. The relation of carcinoma of the pancreas to diabetes mellitus.

Authors:  E T BELL
Journal:  Am J Pathol       Date:  1957 May-Jun       Impact factor: 4.307

5.  Diabetes mellitus in association with primary carcinoma of the pancreas.

Authors:  R C GREEN; A H BAGGENSTOSS; R G SPRAGUE
Journal:  Diabetes       Date:  1958 Jul-Aug       Impact factor: 9.461

6.  Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man.

Authors:  W G Ryan; A F Nibbe; T B Schwartz
Journal:  Lancet       Date:  1967-06-10       Impact factor: 79.321

7.  Insulin reserve in patients with chronic pancreatitis.

Authors:  B I Joffe; S Bank; W P Jackson; P Keller; I G O'Reilly; A I Vinik
Journal:  Lancet       Date:  1968-10-26       Impact factor: 79.321

8.  Use of sequential Bayesian model in diagnosis of jaundice by computer.

Authors:  R P Knill-Jones; R B Stern; D H Girmes; J D Maxwell; R P Thompson; R Williams
Journal:  Br Med J       Date:  1973-03-03

9.  Plasma insulin in pancreatic disease.

Authors:  M F Anderson; S H Davison; A P Dick; C N Hales; J Owens
Journal:  Gut       Date:  1970-06       Impact factor: 23.059

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

  10 in total
  4 in total

1.  Glucose intolerance and pancreatic endocrine dysfunction in dogs with obstructive jaundice.

Authors:  H Obata; A Koga
Journal:  Gastroenterol Jpn       Date:  1988-12

2.  Alteration of the Langerhans islets in pancreatic cancer patients.

Authors:  B M Schmied; A B Ulrich; H Matsuzaki; C Li; H Friess; M W Böchler; A Andron-Sandberg; T E Adrian; P M Pour
Journal:  Int J Pancreatol       Date:  2000-12

3.  Diagnosis of pancreatic cancer. Alteration of glucose metabolism.

Authors:  J Permert; J Larsson; I Ihse; P M Pour
Journal:  Int J Pancreatol       Date:  1991

4.  Alterations in key carbohydrate-metabolizing enzyme activities in rat livers following bile duct ligation and its release.

Authors:  K Hirata; H Mimura; K Orita
Journal:  Jpn J Surg       Date:  1988-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.